EngTree
Manufacturing & process plants
Manufacturing & process plantsBiopharmaceutical Manufacturing (Cell and Gene Therapy)

Oxford Biomedica Harrow House Facility Expansion

Oxford, UK · Ongoing (expansion scheduled for completion in 2016, continuous upgrades implied) · Significant, not explicitly stated for Harrow House alone (broader investments in facilities)

The judgement call

Account-gated at launch

Harrow House is a purpose-built manufacturing facility for cell and gene therapy, highlighting Oxford Biomedica's specialization in this cutting-edge field. - The continuous capacity expansion and successful MHRA inspections underscore the critical need for robust quality systems and regulatory adherence in biopharmaceutical manufacturing. - The focus on viral vector manufacturing is key to the delivery of gene therapies, positioning Oxford Biomedica as a vital CDMO in the sector.

Key engineering challenges

Expanding GMP-compliant manufacturing capacity for viral vectors. - Maintaining stringent quality control and regulatory compliance in cell and gene therapy production. - Integrating advanced bioprocessing technologies for viral vector manufacturing. - Scaling up production to meet demand for clinical and commercial supply.

Project facts

Client / owner
Oxford Biomedica
Lead contractor
Lead designers
Project type
expansion | upgrade
Scale
Purpose-built manufacturing facility; further capacity expansion; 2 vector substance suites; 1 vector product suite; 1 expansion-ready GMP suite.
Disciplines
bioprocess engineering; chemical engineering; mechanical; electrical; civil; structural; cleanroom technology
Standards & frameworks
GMP (Good Manufacturing Practices), MHRA regulations

Sources: OXB.com (https://oxb.com/company/facilities/) - Fierce Pharma (Jan 2016, https://www.fiercepharma.com/manufacturing/oxford-biomedica-announces-successful-mhra-inspection-and-approval-to-manufacture-at) - Pharmaceutical Manufacturer (Jul 2023, https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/pharma-finance-and-investment-news/kadans-expands-relationship-with-oxford-biomedica-/) - LinkedIn (OXB, https://www.linkedin.com/company/oxford-biomedica)